Molecular and spatial differences in the tumor microenvironment of high-grade serous ovarian cancers with short versus long-term survival
OBJECTIVE: Survival of patients diagnosed with advanced-stage high-grade serous ovarian cancer (HGSOC) varies widely. Understanding the biological and molecular differences between tumors associated with short-term and long-term survival may inform prognosis and treatment. METHODS: Omental tumor samples were collected from 15 short-term survivors (STS; <12 months) and 15 long-term survivors (LTS; ≥ 120 months) with stage III-IV HGSOC who underwent primary debulking surgery followed by platinum-based chemotherapy. Bulk tumor sections were analyzed using whole-genome RNA sequencing. Corresponding H&E-stained whole-slide images were processed using machine learning-based cell segmentation to identify cell phenotypes. Computational image analysis was used to extract morphometric features. The integrated transcriptomic and image-derived data were used to quantify proportions of cancer cells, fibroblasts, and immune cells, and to identify differences in nuclear texture, cancer cell spatial organization, and collagen architecture. RESULTSS: STS was associated with higher fibroblast content (48.6% vs 33.5%, p < 0.05), lower cancer cell content (48.0% vs 64.3%, p < 0.05), and a lower tumor-fibroblast proportion (0.9 vs 1.8, p < 0.05) than LTS. Computational image analyses identified significant differences in nuclear texture, cancer cell spatial organization, and collagen architecture. STS correlated with upregulation of fibroblast-associated genes (ITGAV, p < 0.05; INHBA, p < 0.0001) and epithelial-mesenchymal transition markers (ZEB1, p < 0.001; CALD1, p < 0.001), while LTS was enriched for immune signaling pathways. CONCLUSIONS: Omental metastases from STS and LTS patients have distinct molecular and spatial profiles. The enrichment of fibroblast-associated gene signatures in STS and immunoreactive pathways in LTS underscores a divergent tumor microenvironment with potential clinical relevance.
Authors
- Arkadiusz Gertych (ORCID: https://orcid.org/0000-0002-3107-602X)
- Ann E. Walts (ORCID: https://orcid.org/0000-0002-6893-5748)
- Sandra Oršulić (ORCID: https://orcid.org/0000-0001-5119-8721)
- Natalia Zurek
- Beth Y. Karlan
- Barbie Taylor-Harding
- Alexandra H. Smick
Institutions
- Cedars-Sinai Medical Center (US)
- University of California, Los Angeles (US)
- VA Greater Los Angeles Healthcare System (US)
Publication Details
- Journal
- Gynecologic Oncology
- Published
- 2026-05-23
- DOI
- https://doi.org/10.1016/j.ygyno.2026.05.017
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- U.S. Department of Veterans Affairs
- National Cancer Institute
- David Geffen School of Medicine, University of California, Los Angeles